Home Applications 022345 Application 022345
Type NDA
Sponsor GLAXOSMITHKLINE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 POTIGA EZOGABINE TABLET;ORAL 50MG Yes No 002 POTIGA EZOGABINE TABLET;ORAL 200MG Yes No 003 POTIGA EZOGABINE TABLET;ORAL 300MG Yes No 004 POTIGA EZOGABINE TABLET;ORAL 400MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022345-001 POTIGA EZOGABINE 50MG TABLET / ORAL RLD 2011-06-10 N022345-002 POTIGA EZOGABINE 200MG TABLET / ORAL RLD 2011-06-10 N022345-003 POTIGA EZOGABINE 300MG TABLET / ORAL RLD 2011-06-10 N022345-004 POTIGA EZOGABINE 400MG TABLET / ORAL RLD 2011-06-10
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 5 · 176 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 4b0b4de00fa7…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 3 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0173-0810 POTIGA ezogabine GlaxoSmithKline LLC NDA Current 0173-0812 POTIGA ezogabine GlaxoSmithKline LLC NDA Current 0173-0814 POTIGA ezogabine GlaxoSmithKline LLC NDA Current